Search Results

You are looking at 11 - 20 of 31 items for :

  • 5 alpha-reductase x
  • Refine by Access: All content x
Clear All
Open access

Michael Ulm, Arvind V Ramesh, Keely M McNamara, Suriyan Ponnusamy, Hironobu Sasano, and Ramesh Narayanan

.0b013e31823874a4 ) 10.2310/JIM.0b013e31823874a4 16 Kim EH Brockman JA Andriole GL. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia . Asian Journal of Urology 2018 5 28 – 32 . ( https://doi.org/10

Open access

Karim Gariani and François R Jornayvaz

://doi.org/10.1016/j.jhep.2014.11.002 ). 83 Livingstone DE Barat P Di Rollo EM Rees GA Weldin BA Rog-Zielinska EA MacFarlane DP Walker BR Andrew R 5Alpha-reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic

Open access

Clarissa Souza Barthem, Camila Lüdke Rossetti, Denise P Carvalho, and Wagner Seixas da-Silva

: protein kinase AMP-activated catalytic subunit alpha 1 ( Prkaa1 ) and alpha 2 ( Prkaa2 ) ( Fig. 4D ). Figure 4 AMPK levels in the liver. (A) Western blotting for pAMPK ( n  = 8–10) and (B) total AMPK (tAMPK) ( n  = 5). Fifteen micrograms of total

Open access

Emmanuelle Motte, Anya Rothenbuhler, Stephan Gaillard, Najiba Lahlou, Cécile Teinturier, Régis Coutant, and Agnès Linglart

’Neil DM Libé R Allolio B Bertagna X Bertherat J , et al . Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5alpha-reductase, explaining the need for personalized glucocorticoid and androgen replacement . Journal of Clinical

Open access

Stephen J Winters, Charles R Scoggins, Duke Appiah, and Dushan T Ghooray

). SHBG levels are lower with obesity ( 2 ) and in patients with type 2 (T2DM) but not type 1 diabetes ( 3 , 4 ), and in those with the metabolic syndrome (MetS) ( 5 ). Moreover, a low level of SHBG is associated with an increased risk for developing MetS

Open access

Ningning Gong, Cuixia Gao, Xuedi Chen, Yu Wang, and Limin Tian

atherosclerosis (AS) was reported in a large population-based study ( 2 , 3 ). Multiple lines of evidence have shown that adipokines ( 4 ), endothelial dysfunction ( 5 ) and dyslipidemia ( 6 ) play a central role in the development of AS, but the relationship

Open access

Lisette van Alewijk, Kirsten Davidse, Karlijn Pellikaan, Judith van Eck, Anita C S Hokken-Koelega, Theo C J Sas, Sabine Hannema, Aart J van der Lely, and Laura C G de Graaff

-alpha reductase deficiency could be harder to remember than disorders like Klinefelter syndrome, this might suggest that almost one-third of the patients are not sufficiently informed about their condition at the moment of transfer to adult healthcare

Open access

Kylie D Rock, Brian Horman, Allison L Phillips, Susan L McRitchie, Scott Watson, Jocelin Deese-Spruill, Dereje Jima, Susan Sumner, Heather M Stapleton, and Heather B Patisaul

.1016/j.brainresrev.2010.06.002 ) 10.1016/j.brainresrev.2010.06.002 20550950 51 Poletti A Celotti F Rumio C Rabuffetti M Martini L . Identification of type 1 5alpha-reductase in myelin membranes of male and female rat brain. Molecular and Cellular

Open access

Sebastião Freitas de Medeiros, Cinthia Marenza Ormond, Matheus Antônio Souto de Medeiros, Nayara de Souza Santos, Camila Regis Banhara, and Márcia Marly Winck Yamamoto

cytochrome P450c17alpha dysregulation . Human Reproduction 1997 12 910 – 913 . ( doi:10.1093/humrep/12.5.910 ) 10.1093/humrep/12.5.910 13 Lobo RA Goebelsmann UWE. Evidence for reduced 3β-ol-hydroxysteroid dehydrogenase activity in some

Open access

Annette Mouritsen, Alexander Siegfried Busch, Lise Aksglaede, Ewa Rajpert-De Meyts, and Anders Juul

15 and UGT2B17 are critical enzymes for the local inactivation of androgens ( 5 ). The circulating T is converted to DHT, a potent androgen receptor agonist, by 5α-reductase. As it is extremely important to modulate DHT levels locally, the